These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
142 related items for PubMed ID: 16406300
1. Serum insulin-like growth factor-axis and matrix metalloproteinases in patients with rheumatic arthritis or rheumatic heart disease. Lee SD, Chen LM, Kuo WW, Shu WT, Kuo WH, Huang EJ, Tsai CC, Li PC, Liu JY, Chen TH, Huang CY. Clin Chim Acta; 2006 May; 367(1-2):62-8. PubMed ID: 16406300 [Abstract] [Full Text] [Related]
2. Role of the growth hormone/insulin-like growth factor-1 paracrine axis in rheumatic diseases. Denko CW, Malemud CJ. Semin Arthritis Rheum; 2005 Aug; 35(1):24-34. PubMed ID: 16084221 [Abstract] [Full Text] [Related]
3. IGF-1, IGFBP-3, VEGF and MMP-9 levels and their potential relationship with renal functions in patients with compensatory renal growth. Yildiz B, Kural N, Colak O, Ak I, Akcar N. Clin Physiol Funct Imaging; 2008 Mar; 28(2):107-12. PubMed ID: 18093232 [Abstract] [Full Text] [Related]
4. Insulin-like growth factor (IGF)-I, IGF-II and IGF-binding protein (IGFBP)-3 levels in Arab subjects with coronary heart disease. Akanji AO, Suresh CG, Al-Radwan R, Fatania HR. Scand J Clin Lab Invest; 2007 Mar; 67(5):553-9. PubMed ID: 17763192 [Abstract] [Full Text] [Related]
5. Regulation of human villous trophoblast by insulin-like growth factors and insulin-like growth factor-binding protein-1. Hills FA, Elder MG, Chard T, Sullivan MH. J Endocrinol; 2004 Dec; 183(3):487-96. PubMed ID: 15590975 [Abstract] [Full Text] [Related]
6. Growth hormone replacement decreases plasma levels of matrix metalloproteinases (2 and 9) and vascular endothelial growth factor in growth hormone-deficient individuals. Randeva HS, Lewandowski KC, Komorowski J, Murray RD, O'Callaghan CJ, Hillhouse EW, Stepien H, Shalet SM. Circulation; 2004 May 25; 109(20):2405-10. PubMed ID: 15123527 [Abstract] [Full Text] [Related]
7. Association between insulin-like growth factor status and physical activity levels in rheumatoid arthritis. Lemmey A, Maddison P, Breslin A, Cassar P, Hasso N, McCann R, Whellams E, Holly J. J Rheumatol; 2001 Jan 25; 28(1):29-34. PubMed ID: 11196538 [Abstract] [Full Text] [Related]
8. Cachexia in rheumatoid arthritis is associated with inflammatory activity, physical disability, and low bioavailable insulin-like growth factor. Engvall IL, Elkan AC, Tengstrand B, Cederholm T, Brismar K, Hafstrom I. Scand J Rheumatol; 2008 Jan 25; 37(5):321-8. PubMed ID: 18666027 [Abstract] [Full Text] [Related]
9. Raised serum levels of matrix metalloproteinase-9 in women with polycystic ovary syndrome and its association with insulin-like growth factor binding protein-1. Liu B, Cai LY, Lv HM, Xia L, Zhang YJ, Zhang HX, Guan YM. Gynecol Endocrinol; 2008 May 25; 24(5):285-8. PubMed ID: 18569034 [Abstract] [Full Text] [Related]
10. Characterization of the IGF system in 15 patients with Alström syndrome. Maffei P, Boschetti M, Marshall JD, Paisey RB, Beck S, Resmini E, Collin GB, Naggert JK, Milan G, Vettor R, Minuto F, Sicolo N, Barreca A. Clin Endocrinol (Oxf); 2007 Feb 25; 66(2):269-75. PubMed ID: 17223998 [Abstract] [Full Text] [Related]
11. Growth hormone/insulin-like growth factor axis in patients with subclinical thyroid dysfunction. Akin F, Yaylali GF, Turgut S, Kaptanoglu B. Growth Horm IGF Res; 2009 Jun 25; 19(3):252-5. PubMed ID: 19111490 [Abstract] [Full Text] [Related]
12. Serum IGF-1, IGFBP-3 and growth hormone levels in children with congenital heart disease: relationship with nutritional status, cyanosis and left ventricular functions. Dinleyici EC, Kilic Z, Buyukkaragoz B, Ucar B, Alatas O, Aydogdu SD, Dogruel N. Neuro Endocrinol Lett; 2007 Jun 25; 28(3):279-83. PubMed ID: 17627262 [Abstract] [Full Text] [Related]
13. Effect of weight loss on free insulin-like growth factor-I in obese women with hyposomatotropism. Rasmussen MH, Juul A, Hilsted J. Obesity (Silver Spring); 2007 Apr 25; 15(4):879-86. PubMed ID: 17426323 [Abstract] [Full Text] [Related]
14. Pro-inflammatory states and IGF-I level in ischemic heart disease with low or high serum iron. Lee SD, Huang CY, Shu WT, Chen TH, Lin JA, Hsu HH, Lin CS, Liu CJ, Kuo WW, Chen LM. Clin Chim Acta; 2006 Aug 25; 370(1-2):50-6. PubMed ID: 16793032 [Abstract] [Full Text] [Related]
15. Serum levels of insulin-like growth factor-I and -II and insulin-like growth factor binding protein 3 in women with squamous intraepithelial lesions and cervical cancer. Serrano ML, Romero A, Cendales R, Sánchez-Gómez M, Bravo MM. Biomedica; 2006 Jun 25; 26(2):258-68. PubMed ID: 16925098 [Abstract] [Full Text] [Related]
16. Pregnancy-induced changes in insulin-like growth factor I (IGF-I), insulin-like growth factor binding protein 3 (IGFBP-3), and acid-labile subunit (ALS) in patients with growth hormone (GH) deficiency and excess. Wiesli P, Zwimpfer C, Zapf J, Schmid C. Acta Obstet Gynecol Scand; 2006 Jun 25; 85(8):900-5. PubMed ID: 16862465 [Abstract] [Full Text] [Related]
17. Free dissociable insulin-like growth factor I (IGF-I), total IGF-I and their binding proteins in girls with Turner syndrome during long-term growth hormone treatment. Bannink EM, van Doorn J, Stijnen T, Drop SL, de Muinck Keizer-Schrama SM. Clin Endocrinol (Oxf); 2006 Sep 25; 65(3):310-9. PubMed ID: 16918949 [Abstract] [Full Text] [Related]
18. Levels of plasma insulin-like growth factor I (IGF I), IGF II, IGF binding proteins, type 1 IGF receptor and growth hormone binding protein in community-dwelling elderly subjects with no malnutrition and no inflammation. Raynaud-Simon A. J Nutr Health Aging; 2003 Sep 25; 7(4):267-73. PubMed ID: 12917753 [Abstract] [Full Text] [Related]
19. Serum IGF-I, IGFBP-3, and matrix metalloproteinase-7 levels and acquired chemo-resistance in advanced colorectal cancer. Gallego R, Codony-Servat J, García-Albéniz X, Carcereny E, Longarón R, Oliveras A, Tosca M, Augé JM, Gascón P, Maurel J. Endocr Relat Cancer; 2009 Mar 25; 16(1):311-7. PubMed ID: 19109398 [Abstract] [Full Text] [Related]